Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Baclofen as Add-On to Standard Treatment of Alcohol- Dependent Patients and Its Effect on Quality of Life, Clinical and Psychosocial Features: A 12-Week Double-Blind Randomized Controlled Trial

NCT01002105 is registered in ClinicalTrials.gov with Sha'ar Menashe Mental Health Center as lead sponsor.

NCT NCT01002105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01002105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Baclofen as Add-On to Standard Treatment of Alcohol- Dependent Patients and Its Effect on Quality of Life, Clinical and Psychosocial Features: A 12-Week Double-Blind Randomized Controlled Trial
Lead sponsor
Sha'ar Menashe Mental Health Center
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2010
Completion date
December 31, 2012
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence